Turkish Journal of
GERIATRICS

Ege Üniversitesi Tıp Fakültesi, Fiziksel Tıp ve Rehabilitasyon Anabilim Dalı, İZMİR EULAR OA Task Force undertook a project to develop evidence-based recommendations for diagnosis of hand and knee OA as there was no guideline primarily for the purpose of clinical diagnosis of osteoarthritis. However, several guidelines were published for the treatment of OA. In this review, the following guidelines related to the treatment were taken into consideration: EULAR knee OA (2003), EULAR hip OA (2005), EULAR hand OA (2007), OARSI hip and knee (2008) treatment recommendations and NICE clinical guideline (2008). Paracetamol is the oral analgesic to try fi rst. Topical applications (NSAID, capsaicin) have clinical effi cacy and are safe. In patients with an increased gastrointestinal risk, non-selective NSAIDs and effective gastroprotective agents, or selective COX 2 inhibitors should be used. Opioid analgesics, with or without paracetamol, are useful alternatives in patients in whom NSAIDs, including COX 2 selective inhibitors, are contraindicated, ineffective, and/or poorly tolerated. SYSADOA (glucosamine sulphate, chondroitin sulphate, ASU, diacerein, and hyaluronic acid) have symptomatic effects and may modify structure Intraarticular injection of long acting corticosteroid is indicated for fl are of knee pain, especially if accompanied by effusion. Keywords : Osteoarthritis, Knee, Osteoarthritis, Hip, Guideline